Merck #39;s Missing Vioxx Study NEW YORK - Should Merck have conducted a bigger trial to test the safety of its arthritis drug Vioxx? Merck (nyse: MRK - news - people ) pulled Vioxx from the market two weeks ago, but questions about the 